CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 61 filers reported holding CASI PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $40,000 | -97.4% | 33,399 | -94.7% | 0.00% | -96.4% |
| Q1 2021 | $1,512,000 | +149.9% | 630,002 | +207.0% | 0.03% | +115.4% |
| Q4 2020 | $605,000 | +92.7% | 205,200 | 0.0% | 0.01% | +85.7% |
| Q3 2020 | $314,000 | -38.8% | 205,200 | 0.0% | 0.01% | -30.0% |
| Q2 2020 | $513,000 | +74.5% | 205,200 | +42.4% | 0.01% | +42.9% |
| Q1 2020 | $294,000 | – | 144,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields & Co., LLC | 896,137 | $4,185,000 | 2.27% |
| Wellington Shields Capital Management, LLC | 888,333 | $4,149,000 | 0.67% |
| Manatuck Hill Partners, LLC | 15,090 | $70,000 | 0.03% |
| IHT Wealth Management, LLC | 10,725 | $50,000 | 0.01% |
| Perceptive Advisors | 43,682 | $204,000 | 0.01% |
| ALPS ADVISORS INC | 153,234 | $716,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 78,742 | $368,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 5,863 | $28,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,974 | $28,000 | 0.00% |
| METROPOLITAN LIFE INSURANCE CO/NY | 18,585 | $86,792 | 0.00% |